Graylight Innovations announced the acquisition of 90% shares in Future Processing Healthcare, thereby changing its name to Graylight Imaging—conforming with their already existing market brand. Graylight Imaging, through the combination of advanced artificial intelligence technologies and deep knowledge in the field of medical imaging, will be able to provide doctors with incredibly precise diagnostic tools. The new solutions will allow for faster and more accurate diagnosis of heart diseases, cancers, and neurological diseases, resulting in better treatment outcomes and higher quality of life for patients.
Innovative Solutions Using AI for Diagnostics
Imaging diagnostics is experiencing a real revolution, opening new horizons for medicine. Thanks to technologies like computer tomography, magnetic resonance, or ultrasonography, doctors can detect diseases with incredible precision at an early stage. This is particularly important for conditions such as heart attacks which often develop without conspicuous symptoms. Artificial intelligence, by introducing automation into the diagnostic process, allows for even faster and more accurate interpretation of test results, translating into the effectiveness of treatment and the improvement of patients’ quality of life. Imaging diagnostics has become an integral element of modern medicine, enabling both early diagnosis and effective monitoring of disease progression.
Heart Diseases: The Main Cause of Death Worldwide
Cardiovascular diseases pose the greatest threat to human health worldwide. Over 50 million people in Europe alone struggle with them. Every 50 seconds, someone dies from a heart attack or stroke. This is akin to a city the size of Copenhagen disappearing from our continent each year.
Why do so many people die prematurely? The main culprit is atherosclerosis – a disease that causes narrowing of the arteries. The earlier we detect atherosclerotic changes, the better the chances for effective lifestyle changes, optimally chosen treatment, and improving the quality of life. Unfortunately, most often, the diagnosis is made too late when the disease is already advanced.
Luckily, innovative solutions are emerging that could transform cardiology diagnostics. Modern technologies such as artificial intelligence allow for faster and more accurate assessment of the heart’s condition. Thanks to these, even the slightest changes in the arteries can be detected before severe symptoms appear.
Why is this so important? Early diagnosis is key to successful treatment of heart diseases, cancer, and all lifestyle diseases. It enables prevention of heart attacks and strokes, minimization of the risk of complications, improved patients’ quality of life, and reduced costs related to treating advanced stages of the disease and its complications.
Advanced Computer Tomography Image Analysis Technology
Graylight Imaging specializes in creating medical software based on artificial intelligence (AI) and machine learning (ML), which allows for more accurate and faster analysis of medical images. The company’s flagship product is their innovative technology used for analyzing computer tomography images of the heart.
Why is this solution so important in cardiology? Firstly, it will provide an early warning of danger. Imagine having a tool that allows you to see the first signs of disease before it fully develops and presents any symptoms. This is what Graylight Imaging technology offers. With advanced artificial intelligence, it will be able to detect even the smallest changes in the arteries, enabling early health investment and effective treatment.
“In a world where heart diseases remain the biggest health threat, Graylight Imaging technology emerges as a breakthrough solution. It’s not just software, but an intelligent partner for cardiologists that is revolutionizing the way we diagnose and treat heart diseases” emphasizes Prof. Maciej Banach.
Secondly, faster diagnosis means more time dedicated to the patient. In many cases, every minute saved matters when it comes to heart health. The solution will expedite the diagnostic process by automating many time-consuming tasks, allowing doctors to focus on what’s most important—the patient’s health.
Thirdly, the system developed by Graylight Imaging is not only fast but especially precise. Artificial intelligence algorithms will analyze computer tomography images with remarkable accuracy, minimizing the risk of diagnostic errors.
Most importantly, this tool will be available to everyone, as one of its fundamental objectives is to guarantee all patients access to state-of-the-art diagnostics. Thanks to this solution, even people living in smaller towns will be able to benefit from the latest medical achievements.
Graylight Imaging: Innovation for Cardiology
Graylight Imaging is a leading partner for medical companies, providing comprehensive software solutions grounded on artificial intelligence. Currently, they are developing one of the most advanced AI-based technologies worldwide dedicated to imaging diagnostics, particularly in the field of heart diseases.
A team of experts in artificial intelligence, software engineering, and IT security supports the clients in the creation of advanced solutions for the medical sector.
“The acquisition of a significant stake in Future Processing Healthcare by Graylight Innovations is a breakthrough moment for the medical industry. Thanks to the synergy of key skills in the field of artificial intelligence and medical imaging, we can deliver even more precise diagnostic tools that will transform cardiology. Most importantly, it will allow for the very early recognition of atherosclerosis changes and ultimately prevent heart and vascular diseases—the biggest killer in Poland, responsible for 160,000 deaths each year,” says Prof. Maciej Banach, cardiologist, professor of medical sciences, co-owner of Graylight Imaging.
“Our goal is to create a future where cardiac diagnostics is faster, more accurate, and more accessible to everyone. Thanks to advanced artificial intelligence algorithms, we can detect heart diseases at an earlier stage, leading to better prospects for patients,” adds Aniela Hejnowska, a specialist in managing business scaling organizations, co-owner of Graylight Imaging.
The new shareholders of Graylight Imaging include Aniela Hejnowska, an expert in managing organizations in the e-commerce, health and new technologies sectors, Prof. Maciej Banach, a cardiologist, researcher – one of the most cited scientists in Europe, Chairman of the International Panel of Lipid Experts, academic teacher at the Medical University of Lodz or Johns Hopkins University in Baltimore, and Dr. Jarosław Bułka, an expert in AI, digital transformation, and telemedicine – outstanding specialists in their fields. In the group of owners are also Szymon Janota, long-standing president of Future Processing Healthcare and Ewa Kieczka – Baranowska, former Head of Business and People at Future Processing Healthcare. Both have been associated with the IT industry and have been involved in the company since its inception. Simultaneously with the ownership changes, the Company launches an unprecedented employee share option program involving the entire current team of Graylight Imaging.
The knowledge and experience of the ownership team, combined with the existing team of experts in computer science, medicine, and physics, create a unique environment for the development of innovative health solutions, particularly in cardiology.
Combining Science and Business
Graylight Imaging is not just a tech company. The team also conducts intensive research work, the fruits of which include publications in prestigious scientific journals and presentations at international conferences.
“Our team consists of top-class specialists, but also enthusiasts who combine knowledge in medicine, bioengineering, computer science, and artificial intelligence. As such, we can create innovative diagnostic tools that set new standards in cardiology. Our commitment to scientific research translates into the continuous development of our products and enables us to offer patients the best possible care. Additionally, as an international company, we are collaborating with leaders in the medical market worldwide. This allows us to draw from the latest scientific achievements and implement them into our products,” emphasizes Ewa Kieczka–Baranowska, co-owner of Graylight Imaging.
“Our research is financed both from our funds and from research grants, which allows us to carry out ambitious projects. Thanks to them, we can not only improve existing solutions but also create entirely new products. Our research contributes to the development of medicine and improving patients’ quality of life worldwide. We are confident that through our joint efforts, we can build a healthier future for all,” concludes Aniela Hejnowska.
Source: https://managerplus.pl/graylight-innovations-przejmuje-future-processing-healthcare-i-rozwija-technologie-ai-w-diagnostyce-medycznej-55337
